skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

The 2021 Citeline Awards winners by category:

  • Best Patient-facing Technology Initiative: myMedidata by Medidata
  • Best Use of Artificial Intelligence in Clinical Trials: Ciitizen
  • Best Sponsor-facing Technology Initiative: Medidata's Digital Oversight Solution
  • Champion of Diversity & Inclusion in Clinical Research - Sponsored by Parexel: Moderna
  • Most Successful Early Phase Research (Preclinical & Phase I): Orca Bio
  • Clinical Research Team of the Year: PPD, Vaccines Therapeutic Unit and Moderna
  • Clinical Trial Result of the Year: Novavax’ PREVENT-19 Clinical Trial
  • Excellence in Rare Disease Drug Development: BridgeBio Pharma
  • Most Innovative Start-up Company: Generate Biomedicines
  • Clinical Partnership of the Year: Humanigen and CTI Clinical Trial & Consulting Lenzilumab Team
  • Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities: CluePoints and Pfizer / BioNTech
  • Excellence in Innovation in Response to COVID-19 - Healthcare & Diagnostics: Sherlock Biosciences
  • Marquee Award: Eli Lilly

 

London, UK – 8th April 2022 - Last night, the winners of the Citeline Awards 2021 were announced at the Hyatt Regency Boston, MA, USA. The Citeline Awards recognize a myriad of accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers.

The Citeline Awards 2021 span 13 categories, covering a spectrum of key R&D activities, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and execution.

Best Patient-facing Technology Initiative: Designed for patients, by patients, myMedidata by Medidata provides the industry’s most comprehensive, integrated solution for patient-centred research.

Best Use of Artificial Intelligence in Clinical Trials: Ciitizen uses unique technology for patient record aggregation and structuring advances to solve information efficiencies in clinical trial recruitment and enrolment.

Best Sponsor-facing Technology Initiative: Medidata's Digital Oversight Solution revolutionizes clinical monitoring strategies, enabling a move toward a truly virtualized monitoring experience.

Champion of Diversity & Inclusion in Clinical Research - Sponsored by Parexel: Moderna’s Phase III COVE Study (mRNA-1273-P301) of its COVID-19 vaccine quickly and successfully enrolled a patient pool reflecting the diversity of the US population.

Most Successful Early Phase Research (Preclinical & Phase I): Orca Bio’s Orca-T investigational cell therapy for blood cancers significantly improved GvHD and relapse-free survival rates at one year.

Clinical Research Team of the Year: Contract research organization PPD, Vaccines Therapeutic Unit and Moderna partnered to successfully execute the widely impactful COVE study for Moderna’s COVID-19 vaccine.

Clinical Trial Result of the Year: Novavax’s PREVENT-19 clinical trial leveraged innovative technology and a novel vaccine development platform to rapidly develop a COVID-19 vaccine candidate with 100% protection against moderate and severe disease.

Excellence in Rare Disease Drug Development: BridgeBio Pharma’s NULIBRY™ (fosdenopterin) marks a major milestone in the rare disease community and reduces risk of death from the ultra-rare disease MoCD Type A by 82%.

Most Innovative Start-up Company: Generate Biomedicines used its machine learning platform to successfully generate dozens of COVID-19 neutralizing molecules with unprecedented speed.

Clinical Partnership of the Year: Humanigen and CTI Clinical Trial & Consulting Lenzilumab Team successfully brought lenzilumab through a 520-patient Phase III trial and to regulatory submission in just 15 months.

Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities: CluePoints and Pfizer / BioNTech partnered to use risk-based quality management software to successfully speed data analysis in the BNT162b2 COVID-19 vaccine trial.

Excellence in Innovation in Response to COVID-19 - Healthcare & Diagnostics: Sherlock Biosciences’ COVID-19 rapid diagnostics enable identification of a single alteration in a DNA or RNA sequence in a single molecule.

Marquee Award: Eli Lily was recognized for outstanding achievement across the full spectrum of drug development. With nine drug launches in the past seven years, their projects reflect a focus on next generation drugs and demonstrate innovation and commitment to precision medicine, gene therapy, and RNA technologies.

Karen Currie, Executive Director, Editorial, Citeline: “We’re delighted to announce The Citeline Awards winners for 2021. After the difficult period we have all faced, it was fantastic to all be in a room together to celebrate the long-awaited Awards and the achievements of the previous year. Congratulations to all of this year’s winners and a big thank you to our nominees, sponsors and judges who contributed to a great event.”

 

About Informa Pharma Intelligence

Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, medtech and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.

At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers.

For more information visit pharmaintelligence.informa.com.

 

About Citeline

Citeline, part of Informa’s Pharma Intelligence vertical, is the world’s most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines. Citeline is the R&D Intelligence arm of Informa’s Pharma Intelligence vertical, one of the world’s leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: